CPHI Milan 2
CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Healthcare’s Fountain of Youth
Editorial Archive

Healthcare’s Fountain of Youth

The medical revolution is creating the prospect of much longer – and healthier – lives. But achieving the full benefits requires better logistics. Undeniably, aging ...
Continue Reading →
Contact Killing on Copper Surfaces: From Lab to Application
Editorial Archive

Contact Killing on Copper Surfaces: From Lab to Application

As evidence grows for the key role of the environment in the spread of infection, the selection of materials for hygiene-sensitive environments is moving up the agen...
Continue Reading →
Rapid and Traditional Methods in the Contract Microbiology Laboratory
Editorial Archive

Rapid and Traditional Methods in the Contract Microbiology Laboratory

In the world of contract testing, we are bound by regulatory guidelines and high client expectations. We perform the necessary safety and performance testing of phar...
Continue Reading →
Orphan Drug Trials: Putting the Patient First
Clinical Research v7i3

Orphan Drug Trials: Putting the Patient First

Over recent years, there has been a notable increase in the number of orphan drugs being successfully brought to market. Here, Jennifer Peters of Greenphire speaks t...
Continue Reading →
Delivering Patient-centric Support Services in Clinical Trials
Clinical Research v7i3

Delivering Patient-centric Support Services in Clinical Trials

While patient safety is paramount in clinical trials, there are a number of additional key patient concerns, including recruitment, engagement, retention and complia...
Continue Reading →
Comparator Sourcing – An Analytical Approach to Find Best Suited Sourcing Strategies
Clinical Research v7i3

Comparator Sourcing – An Analytical Approach to Find Best Suited Sourcing Strategies

Sourcing comparator drugs for clinical trials is a complex process, especially for branded drugs, and in many cases the selection process to find the best sourcing p...
Continue Reading →
Drug Metabolite Synthesis with Human Enzymes: How Can We Utilise Microbes to Make Authentic Human Metabolites?
Drug Discovery, Development and Delivery v7i3

Drug Metabolite Synthesis with Human Enzymes: How Can We Utilise Microbes to Make Authentic Human Metabolites?

The characterisation of the metabolic fate of a new drug molecule is essential in the course of the drug discovery and development process. As a consequence, potenti...
Continue Reading →
Alzheimer’s Disease – Breakthrough Due Soon?
Drug Discovery, Development and Delivery v7i3

Alzheimer’s Disease – Breakthrough Due Soon?

uggesting the cure for Alzheimer’s disease (AD) is imminent. Why is there so much buzz about a cure for AD? How close is a cure? And just why has it been so difficul...
Continue Reading →
Sifting Through the Sourcing Options
Editorial Archive

Sifting Through the Sourcing Options

Outsourcing is now a widely accepted practice in the life sciences industry. However, choosing precisely which activities to entrust to an external supplier remains ...
Continue Reading →
Entering the Homestretch for ICD-10 Transition
Editorial Archive

Entering the Homestretch for ICD-10 Transition

ICD-10 is the largest mandate in US healthcare history. It will require diligent, comprehensive actions to be fully prepared for the transition. Practices have until...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026